TOPVISION Eye Specialist Bhd
TOPVISION Eye Specialist Bhd has a debt-to-equity ratio of 0.65 and a current ratio of 4.1, indicating a relatively strong liquidity position despite a negative net cash position after subtracting total debt. The company’s free cash flow is negative at -4.54 million MYR, driven by capital expenditures of -6.49 million MYR, which suggests ongoing investment in infrastructure or equipment. Profitability metrics show a return on equity of 4.45% and a return on assets of 2.54%, both below the typical thresholds for high-margin healthcare services. This suggests the company is generating modest returns relative to its equity and asset base. Operating income of 5.65 million MYR and a gross profit of 22.87 million MYR indicate a stable but not exceptional performance in cost management and pricing. The company operates through multiple branches across Malaysia, including locations in Setia Alam, Banting, and Johor Bahru, with no disclosed segmental revenue breakdown. This lack of segmental data limits visibility into geographic or service-line concentration risks. Revenue for the latest period is 45.81 million MYR, with no disclosed growth rate or outlook. The absence of forward-looking guidance and limited historical data makes it difficult to assess the company’s growth trajectory. Risk factors include a medium liquidity risk due to negative net cash and a current reliance on operating cash flow of 6.98 million MYR to fund operations. The dilution risk is assessed as low, with no near-term pressure from share issuance or convertible instruments. Recent events include no disclosed filings or transcripts, and the company’s financial disclosures are limited to standard balance sheet and income statement items. This suggests a lack of transparency in strategic or operational developments.
Business. TOPVISION Eye Specialist Bhd provides ophthalmology services and related medical consultancy in Malaysia, operating through multiple branches and subsidiaries focused on treating eye conditions such as cataract, diabetic retinopathy, and glaucoma.
Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92 based on verified market data.
- The company maintains a strong current ratio of 4.1 but faces liquidity challenges due to negative net cash after debt.
- Return on equity and return on assets are below typical thresholds for healthcare service providers, indicating modest profitability.
- The company operates in multiple locations across Malaysia but lacks segmental revenue disclosure, limiting visibility into geographic concentration.
- Free cash flow is negative, driven by capital expenditures, suggesting ongoing investment in infrastructure.
- Dilution risk is low, and no near-term share issuance pressure is evident.
- --
- # RATIONALES
- ```json
- Net cash is negative after subtracting total debt.